These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8017842)
1. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells. Kawamura I; Lacey E; Mizota T; Tsujimoto S; Nishigaki F; Manda T; Shimomura K Anticancer Res; 1994; 14(2A):427-31. PubMed ID: 8017842 [TBL] [Abstract][Full Text] [Related]
2. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line. Parisot JP; Hu XF; DeLuise M; Zalcberg JR Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856 [TBL] [Abstract][Full Text] [Related]
4. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin]. Gao HD; Sun JZ; Bi DS; Ma R Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells. Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803 [TBL] [Abstract][Full Text] [Related]
6. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture. Jain PT; Pento JT; Magarian RA Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114 [TBL] [Abstract][Full Text] [Related]
7. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers. Kawamura I; Mizota T; Lacey E; Tanaka Y; Manda T; Shimomura K; Kohsaka M Jpn J Pharmacol; 1993 Sep; 63(1):27-34. PubMed ID: 8271528 [TBL] [Abstract][Full Text] [Related]
8. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929 [TBL] [Abstract][Full Text] [Related]
9. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells. Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722 [TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Arteaga CL; Osborne CK Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250 [TBL] [Abstract][Full Text] [Related]
11. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214 [TBL] [Abstract][Full Text] [Related]
12. Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma. Kawamura I; Mizota T; Mukumoto S; Manda T; Masuda K; Nakamura T; Kubota H; Matsumoto S; Nishigaki F; Shimomura K Arzneimittelforschung; 1989 Aug; 39(8):889-93. PubMed ID: 2818677 [TBL] [Abstract][Full Text] [Related]
13. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Chen J; Power KA; Mann J; Cheng A; Thompson LU Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953 [TBL] [Abstract][Full Text] [Related]
14. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Gooch JL; Lee AV; Yee D Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635 [TBL] [Abstract][Full Text] [Related]
15. Growth factors and chemotherapeutic modulation of breast cancer cells. Ciftci K; Su J; Trovitch PB J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904 [TBL] [Abstract][Full Text] [Related]
16. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells. Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470 [TBL] [Abstract][Full Text] [Related]
17. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines. ter Haar E; Day BW Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221 [TBL] [Abstract][Full Text] [Related]
18. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Guvakova MA; Surmacz E Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945 [TBL] [Abstract][Full Text] [Related]
20. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells. van der Burg B; Isbrücker L; van Selm-Miltenburg AJ; de Laat SW; van Zoelen EJ Cancer Res; 1990 Dec; 50(24):7770-4. PubMed ID: 2174732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]